Search Results - johnnie+orozco

1 Results

Sort By:

Novel Bispecific Antibody Targeting CD45

Pretargeted Radioimmunotherapy for the Treatment of of Acute Myeloid LeukemiaAn anti-CD45 bispecific antibody delivering targeted radioimmunotherapy to treat acute myeloid leukemia (AML), while avoiding systemic toxicity. Pretargeted radioimmunotherapy (PRIT) is a two-step approach that delivers radioactivity separate from the initial targeting step....

Published: 2/3/2025 | Updated: 10/25/2018 | Inventor(s): Johnnie Orozco

Keywords(s): Hybridoma / Antibody, Protein / Peptide

Category(s): Therapeutic